CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This research focuses on understanding bacterial cell division to develop new antimicrobial compounds. By elucidating the molecular mechanisms involved, the project aims to identify potential drug targets that can combat multidrug-resistant pathogens, addressing a critical public health challenge.
The world wide rise in multidrug resistant pathogens is a major healthcare problem, and both the World Health Organization and European Union have identified antimicrobial resistance as a public health priority.
The number of novel antibiotics that enter the clinic has dwindled over the last decades, and the development of new antibiotics is urgent.
Cell division is a logical antimicrobial drug target, yet there are currently no clinically approved compounds that target this process.
One of the…
UNIVERSITEIT VAN AMSTERDAM
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
